Last reviewed · How we verify
metronidazole 400mg
At a glance
| Generic name | metronidazole 400mg |
|---|---|
| Also known as | flygel 400mg, Flagyl |
| Sponsor | Dow University of Health Sciences |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Optimization of Minocycline for Helicobacter Pylori Rescue Treatment (PHASE4)
- The LISA (Lactoferrin InStead of Antibiotics/Antifungals) Feasibility Study (NA)
- Eradication of Helicobacter Pylori Subtypes at High Gastric Cancer Risk: a Cluster-randomized Controlled Trial (NA)
- Mechanical Bowel Preparation With or Without Oral Antibiotics in Left Sided Colorectal Cancer Surgery (NA)
- Combination Study of Antibiotics With Enzalutamide (PROMIZE) (PHASE1, PHASE2)
- Rescue Therapy for Helicobacter Pylori Infection (PHASE4)
- Local and Systemic Antimicrobials in Non-surgical Periodontal Therapy (NA)
- Efficacy of an Adapted Antibiotherapy in Hurley Stage 2 Hidradenitis Suppurativa Patients (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- metronidazole 400mg CI brief — competitive landscape report
- metronidazole 400mg updates RSS · CI watch RSS
- Dow University of Health Sciences portfolio CI